SCHEMBL7418599

SCHEMBL7418599

CCC1(C(N)=O)Cc2ccccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
PKM P14618 1/20 0.41
NFKB1 P19838 1/20 0.41
THPO P40225 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NISCH Q9Y2I1 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PPARA Q07869 6/20 0.36
PPARG P37231 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3380544 0.86 PPARA (0.44) CYP2D6TSHRCYP2C19CYP1A2PKM
SCHEMBL7420613 0.86 PPARA (0.44) CYP2D6TSHRCYP2C19CYP1A2PKM
SCHEMBL4383883 0.82 CYP2D6 (0.39) CYP2D6TSHRCYP2C19CYP1A2PKM
Hydrochloric Acid SCHEMBL10545348 0.77 ALOX15 (0.40) ADRA2ASMN1; SMN2MEN1KMT2A
SCHEMBL27465884 0.75 HPGD (0.38) CYP2D6TSHRCYP2C19CYP1A2PKM
SCHEMBL27821524 0.74 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL30613915 0.74 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL16635226 0.74 PPARG (0.59) PPARAPPARGPPARD
SCHEMBL31566188 0.74 PPARG (0.40) PPARAPPARGPPARD
SCHEMBL444321 0.73 CYP2D6 (0.36) CYP2D6TSHRCYP2C19CYP1A2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000076990-A1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2000-12-21 WO disclosed
EP-0824531-B1 METHOD FOR PREPARING AN OPTICALLY PURE BENZOFURAN CARBOXYLIC ACID AND USE THEREOF FOR PREPARING EFAROXAN PF MEDICAMENT (FR) 2000-03-22 EP disclosed
US-5880296-A RACEMIC MIXTURE IS RESOLVED BY SELECTIVE CRYSTALLIZATION WITH THE APPROPRIATE OPTICALLY PURE ENANTIOMER OF 2-PHENYLGLYCINOL; ANTIDEPRESSANT, MIGRAINE DRUG SYNTHESIS PIERRE FABRE MEDICAMENT (FR) 1999-03-09 US disclosed
EP-0824531-A1 METHOD FOR PREPARING AN OPTICALLY PURE BENZOFURAN CARBOXYLIC ACID AND USE THEREOF FOR PREPARING EFAROXAN PIERRE FABRE MEDICAMENT (FR) 1998-02-25 EP disclosed
WO-1996035682-A1 METHOD FOR PREPARING AN OPTICALLY PURE BENZOFURAN CARBOXYLIC ACID AND USE THEREOF FOR PREPARING EFAROXAN PIERRE FABRE MEDICAMENT (FR) 1996-11-14 WO disclosed